Profund Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Profund Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,009	Closed	-$289K	–	1381
2020 Q4	$289K	Buy	+4,009	New	+$210K	0.01%	846
2019 Q2	–	Sell	-3,572	Closed	-$224K	–	1256
2019 Q1	$224K	Sell	3,572 -1,020	-22%	-$70.1K	0.01%	1080
2018 Q4	$274K	Sell	4,592 -1,805	-28%	-$108K	0.02%	820
2018 Q3	$412K	Sell	6,397 -909	-12%	-$50.7K	0.02%	954
2018 Q2	$329K	Buy	+7,306	New	+$291K	0.01%	1101

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Profund Advisors's BEAT Position: Q1 2021 in Review

Profund Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 4,009 shares — an estimated $289K sold.

Profund Advisors first reported a position in BEAT in Q2 2018 and held it in 5 quarters. The position peaked at $412K in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Profund Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Profund Advisors sold 4,009 BioTelemetry, Inc. shares in Q1 2021, an estimated $289K.
Profund Advisors first reported a position in BioTelemetry, Inc. in Q2 2018 and held it in 5 quarters.
Profund Advisors's BioTelemetry, Inc. position peaked at $412K in Q3 2018.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Profund Advisors's 13F filing for Q1 2021, filed 14 May 2021.